Y. Peng

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.

S. Bae, D. D'cruz, D. Wallace, 2010, Arthritis and rheumatism.

Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis

X. Chen, L. Bai, Yi-ming Li, 2022, Pharmaceutics.